Skip to main content
ArticleOPEN ACCESS

Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)

Journal of Hematology and Oncology
DOI: 10.1186/s13045-020-01023-9
2Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The original article [18] mistakenly contains duplicate references. The correct reference list can be viewed in this Correction article.

Cite

CITATION STYLE

APA

Yilmaz, M., Alfayez, M., DiNardo, C. D., Borthakur, G., Kadia, T. M., Konopleva, M. Y., … Daver, N. G. (2021, December 1). Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5). Journal of Hematology and Oncology. BioMed Central Ltd. https://doi.org/10.1186/s13045-020-01023-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free